The procedure was performed at Franciscan St. Francis Health in Carmel, Ind. The implant, which is currently in the pilot launch phase of release, includes specific features designed to achieve axial and rotational mechanical stability between the lateral and medial cortices of the femoral canal.
According to the company, a full launch of the product is expected to take place within the U.S. in January of 2015.
More articles on devices:
Ronda Stryker sells 21k shares in August so far: 5 things to know
StemCells suffers $12M net loss in 2Q preparing spinal injury trial: 5 points
21 spine devices receive FDA 510(k) clearances in July
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
